Pacira BioSciences, Inc.
PCRX· Nasdaq
Released May 2, 2016, during market hours
10-Q filed May 2, 2016, 32 days after period end · 0001628280-16-015255
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|---|
| Revenue | $65.47M | $58.32M | $36.66M | $11.59M |
| Net Income | -$3.85M | $1.26M | -$11.48M | -$23.14M |
| EPS Diluted | -$0.10 |
Pacira BioSciences, Inc. · CIK 1396814 · Engraved from SEC EDGAR
| $0.03 |
| -$0.34 |
| -$0.71 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.